Create Your Blog
  1. Home
  2. Nearly 300 Non-invasive Diagnostic Tests, Designed For The Detection Of Various Types Of Cancers, Are Either Already Available In The Market Or Under Development Across The World

Nearly 300 Non-invasive Diagnostic Tests, Designed For The Detection Of Various Types Of Cancers, Are Either Already Available In The Market Or Under Development Across The World

>

Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.

 

To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this link

 

The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the following segments:

  • Type of Tumor Marker
  • ctDNA
  • cfDNA
  • CTCs
  • Exosomes
  • Others

 

  • Application
  • Diagnosis / Early Diagnosis
  • Patient Monitoring
  • Recurrence Monitoring

 

  • Target Cancer Indication
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Bladder Cancer
  • Melanoma
  • Gastric Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

 

  • End Users
  • Hospitals
  • Research Institutes
  • Others

 

  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

The Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers report features the following companies, which we identified to be key players in this domain:

  • Amoy Diagnostics
  • DiaCarta
  • HaploX Biotechnology
  • NeoGenomics
  • QIAGEN
  • Swift Biosciences
  • Sysmex Inostics
  • Thermo Fisher Scientific

Press Release: Variation 3 (Format 4)

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2.  Introduction

 

  1. Non-Invasive Cancer Screening and Diagnosis

  2. Market Landscape

 

  1. Company Profiles

  2. Partnerships and Collaborations

 

  1. Funding and Investment Analysis

  2. Liquid Biopsy: Initiatives of Big Pharma Players

  3. Key Acquisition Targets

 

  1. Other Non-Invasive Cancer Diagnostics

  2. Market Sizing and Opportunity Analysis

  3. Survey Insights

 

  1. Conclusion

  2. Executive Insights

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Share:

Keywords: market research

Comments

FREE BLOG/SBM SITES
Categories

Other related blogs

Satta King | Satta King Result | Gali Satta | Desawar Satta Result

By : Satta King

The Satta King is a business which was established in 2020 and its main aim is to provide all the fa..

Satta King | Satta King Online | Satta King Result

By : Satta King

Satta King - Be Rich In 2020 - Become One Of The Famous People The Satta King became a billionaire..

2021 | Satta King | Satta King Online | Satta King Result

By : Satta King

The Satta King is a luxury hotel in the heart of New Delhi. This is one of the best locations to sta..

Thinking in a room were parties are sure to RuneScape

By : MMOruki

The rewords will be if you win then you'll receive tickets and that RuneScape gold you will find oui..